CME Presentations
Food Allergy Series
Presentations
Management of Food Allergies: Guideline-based Prevention of Allergic and Anaphylactic Reactions
Speakers: Robert Wood, MD, Professor of PediatricsEdwin Kim, MD, MS, Associate Professor of Pediatrics Duration: 30 minutes
Presented on: September 20, 2023
Defining the Place of Emerging IgE-targeted Therapies in Team-based Management of Food Allergies
Speakers: Robert Wood, MD, Professor of PediatricsJennifer Dantzer, MD, MHS, Assistant Professor of Pediatrics, Division of Allergy Duration: 30 minutes
Presented on: September 20, 2023
Speakers
Robert Wood, MD
Robert Wood, MD
Professor of Pediatrics
Dr. Robert Wood is Professor of Pediatrics, Chief of Pediatric Allergy, Immunology, and Rheumatology, Director of the Pediatric Clinical Research Unit, and Deputy Director of the Institute of Clinical and Translational Research at the Johns Hopkins University School of Medicine. He is recognized internationally as an expert in both food allergy and childhood asthma and has published over 300 manuscripts and book chapters, as well as four books. He has served on numerous editorial boards and other leadership positions, including President of the American Academy of Allergy, Asthma, and Immunology.
Edwin Kim, MD, MS
Edwin Kim, MD, MS
Associate Professor of Pediatrics
Edwin Kim, MD, MS is an associate professor of pediatrics at the University of North Carolina (UNC) School of Medicine and chief of the division of pediatric allergy and immunology. He is director of the UNC Food Allergy Initiative research group, which focuses on multiple aspects of food immunotherapy including safety and tolerability of immunotherapy, varying levels of clinical desensitization, and immune mechanisms involved in successful treatment. Dr. Kim is also interested in research that focuses on the development of novel therapeutics for food allergy. As director, his goal is to recruit and train the next generation of leaders in allergy and immunology through strong clinical training and productive research opportunities.
Jennifer Dantzer, MD, MHS
Jennifer Dantzer, MD, MHS
Assistant Professor of Pediatrics, Division of Allergy
Jennifer Dantzer, MD, MHS is a pediatric allergist and immunologist with a focus on food allergy treatments and patient-centered outcomes. She is an assistant professor of pediatrics at the Johns Hopkins School of Medicine in the division of allergy, immunology, and rheumatology. In 2021, Dr. Dantzer was awarded the Johns Hopkins Clinical Scholar Award and NIH/NIAID K23 award to study patient-centered outcomes of the first FDA-approved food allergy treatment. She is a co-investigator in the Consortium for Food Allergy Research and participates in numerous food allergy research projects. She has published numerous articles in leading allergy and immunology journals, including five review articles on novel treatments for food allergy, and has presented at several national conferences.
CME Information
Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the Asthma and Allergy Foundation of America (AAFA) and Food Allergy Research & Education (FARE).Defining the Place of Emerging IgE-targeted Therapies in Team-based Management of Food Allergies
ACKNOWLEDGEMENT
This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.DATE OF RELEASE/EXPIRATION
This activity was released on September 20, 2023 and is valid until September 20, 2024. Requests for credit must be made no later than September 20, 2024.TARGET AUDIENCE
The educational design of this activity addresses the needs of allergists/immunologists, pediatricians, and primary care clinicians (MDs/DOs/NPs/PAs).STATEMENT OF NEED/PROGRAM OVERVIEW
The global occurrence of food allergies is increasing due to environmental, lifestyle, and nutritional factors.-Food allergies pose heavy emotional, social, and financial impacts on those affected and their families; however, emerging treatments that target the underlying mechanisms of food allergies and common comorbidities are showing promise in clinical trials Increasingly, the onus is on front-line clinicians to counsel patients and families and work with allergists to help break down barriers to accessing appropriate care.
Join a panel of allergy and primary care clinicians to discuss the mechanisms of action and efficacy/safety profiles of emerging anti-immunoglobulin E (IgE) therapies for food allergies and where these agents may fit in the treatment algorithm. Expert panelists will, thus, share the implications and goals of different therapeutic approaches, review when and how to counsel patients as part of shared decision-making, and also identify the roles and responsibilities of each member of the care team involved in the management of food allergies and comorbidities.EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:- Describe current evidence supporting the efficacy and safety of emerging biologics that target the underlying pathophysiology of food allergies and common comorbidities
- Summarize strategies to develop a multidisciplinary, patient-centered approach to the management of people with food allergies and other immunoglobulin E mediated comorbidities
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. PHYSICIAN CONTINUING EDUCATION
PACE designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.ESTIMATED TIME TO COMPLETE
This activity should take approximately 30 minutes to complete.INSTRUCTIONS TO RECEIVE CREDIT
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 75% on the post-test.HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.FEE INFORMATION & REFUND/CANCELLATION POLICY
There is no fee for this educational activity.FACULTY AND DISCLOSURE OF CONFLICTS OF INTEREST
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Name of Faculty or Presenter Conflicts of Interest Jennifer Dantzer, MD, MHS
Assistant Professor of Pediatrics
Pediatric Allergy, Immunology, and Rheumatology
Johns Hopkins School of Medicine
No relevant financial relationship(s) to disclose Robert A. Wood, MD
Professor of Pediatrics and International Health Director, Eudowood Division of Pediatric Allergy, Immunology, and Rheumatology
Director, Pediatric Clinical Research Unit
Johns Hopkins University School of Medicine
Researcher: Aimmune, ALK, DBV, Novartis, Siolta
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The PlatformQ Health Education, LLC planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.CONTACT INFORMATION
Accreditation Support:
For additional information about the accreditation of this activity, please visit https://partnersed.com.Technical Support:
For any technical issues or issues with your CME Certificate, please contact ImmunologyLive at 877-394-1306 or at Support@ImmunologyLive.com.
Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the Asthma and Allergy Foundation of America (AAFA) and Food Allergy Research & Education (FARE).Management of Food Allergies: Guideline-based Prevention of Allergic and Anaphylactic Reactions
ACKNOWLEDGEMENT
This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.DATE OF RELEASE/EXPIRATION
This activity was released on September 20, 2023 and is valid until September 20, 2024. Requests for credit must be made no later than September 20, 2024.TARGET AUDIENCE
The educational design of this activity addresses the needs of allergists/immunologists, pediatricians, and primary care clinicians (MDs/DOs/NPs/PAs).STATEMENT OF NEED/PROGRAM OVERVIEW
Food allergies pose a major health burden on patients, their caregivers, and the healthcare system. Oral immunotherapy (OIT) has shown efficacy raising the threshold of tolerance for certain foods, but it is limited by burdensome regimens, risks of allergic reactions, and the fact that it often targets only one food allergen. An improved understanding of the underlying pathophysiology and role of immunoglobulin E (IgE) in food allergies has led to advances in management.
Join an expert panel of allergy and immunology specialists to review the limitations associated with current approaches to reduce risk of allergic and anaphylactic reactions in people with food allergies. Panelists will discuss current guidelines to manage food allergies in adults and children, as well as newer biologic agents that inhibit mediators of the allergic pathway. Learn how these advances in treatment may allow patients to achieve tolerance to higher amounts of multiple allergens, enhance convenience and adherence, and improve quality of life for patients.EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:- Recognize the limitations and challenges associated with traditional treatment approaches, including oral immunotherapy (OIT), for desensitization and improvement of tolerance to known food allergens
- Apply current evidence-based consensus recommendations for managing food allergies
- Describe current evidence supporting the efficacy and safety of emerging biologics that target the underlying pathophysiology of food allergies and common comorbidities
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. PHYSICIAN CONTINUING EDUCATION
PACE designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.ESTIMATED TIME TO COMPLETE
This activity should take approximately 30 minutes to complete.INSTRUCTIONS TO RECEIVE CREDIT
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 75% on the post-test.HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.FEE INFORMATION & REFUND/CANCELLATION POLICY
There is no fee for this educational activity.FACULTY AND DISCLOSURE OF CONFLICTS OF INTEREST
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Name of Faculty or Presenter Conflicts of Interest Edwin Kim, MD, MS
Associate Professor of Pediatrics
University of North Carolina School of Medicine
Consultant, Advisor, Speaker: ALK, AllerGenis, Belhaven Biopharma, Genentech, Kenota Health, Nutricia, Revolo, Ukko Inc.
Safety Review Committee: Allergy Therapeutic LtdRobert A. Wood, MD
Professor of Pediatrics and International Health Director, Eudowood Division of Pediatric Allergy, Immunology, and Rheumatology
Director, Pediatric Clinical Research Unit
Johns Hopkins University School of Medicine
Researcher: Aimmune, ALK, DBV, Novartis, Siolta
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The PlatformQ Health Education, LLC planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.CONTACT INFORMATION
Accreditation Support:
For additional information about the accreditation of this activity, please visit https://partnersed.com.Technical Support:
For any technical issues or issues with your CME Certificate, please contact ImmunologyLive at 877-394-1306 or at Support@ImmunologyLive.com.
